Liquid-crystalline media having homeotropic alignment

US11072742B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11072742-B2
Application numberUS-201816225694-A
CountryUS
Kind codeB2
Filing dateDec 19, 2018
Priority dateDec 20, 2017
Publication dateJul 27, 2021
Grant dateJul 27, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A liquid-crystalline media (LC media) containing a low-molecular-weight, non-polymer component, and a combination of self-alignment additives for vertical alignment of two or more of the specified kinds (formulae IA to IM). The combination of two or more self-alignment additives affect homeotropic (vertical) alignment of the LC media at a surface or the cell surfaces of a liquid-crystal display (LC display).

First claim

Opening claim text (preview).

The invention claimed is: 1. A liquid-crystal (LC) medium comprising a low-molecular-weight, non-polymerizable liquid-crystalline component and a combination of self-alignment additives for vertical alignment selected from the group consisting of formulae IG and IL combined with one or more compounds selected from the group consisting of formulae IE, IF, IJ and IK in which A 4 , A 5 , A 6 each, independently of one another, denote an aromatic, heteroaromatic, alicyclic or heterocyclic group, which optionally contains fused rings, and which is optionally mono-or polysubstituted by a group L or -Sp-P, A 7 , A 8 , A 9 each, independently of one another, denote an aromatic, heteroaromatic, alicyclic or heterocyclic group, which optionally contains fused rings, and which is optionally mono-or polysubstituted by a group L or -Sp-P, P denotes a polymerizable group, Sp denotes a spacer group or a single bond, wherein formulae IE, IF and IG independently comprise one polymerizable group P each, and wherein formulae IJ, IK and IL independently comprise two or more polymerizable groups P each, L in each case, independently of one another, denotes H, F, CI, Br, I, —CN, —NO 2 , —NCO, —NCS, —OCN, —SCN, —C(═O)N(R 0 ) 2 , —C(═O)R 0 , optionally substituted silyl, optionally substituted aryl or cycloalkyl having 3 to 20 C atoms, or straight-chain alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 3 to 25 C atoms, in which one or more H atoms are each optionally replaced by F or CI, Z 2 , Z 3 in each case, independently of one another, denotes a single bond, —O—, —S—, —CO—, —CO—O—, —OCO—, —O—CO—O—, —OCH 2 —, —CH 2 O—, —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —(CH 2 ) n1 —, —CF 2 CH 2 —, —CH 2 CF 2 —, —(CF 2 ) n1 —, —CH═CH—, —CF═CF—, —C═C—, —CH═CH—COO—, —OCO—CH═CH—, —(CR 0 R 00 ) n1 —, —CH(—Sp-P)—, —CH 2 CH(—Sp-P)—, or —CH(—Sp-P)CH(—Sp-P)—, n1 denotes 1, 2, 3 or 4, m denotes 0, 1, 2, 3, 4, 5 or 6, n denotes 0 or 1, R 0 in each case, independently of one another, denotes alkyl having 1 to 12 C atoms, R 00 in each case, independently of one another, denotes H or alkyl having 1 to 12 C atoms, R 1 denotes H, halogen, straight-chain alkyl having 1 to 25 C atoms, or branched or cyclic alkyl having 3 to 25 C atoms, in which one or more non-adjacent CH 2 groups are each optionally replaced by —O—, —S—, —CO—, —CH═CH—, —C≡C—, —CO—O—, —O—CO—, or —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another and in which one or more H atoms are each optionally replaced by F or Cl, or denotes a group -Sp-P, X 1 each, independently of one another, denotes —OH, —SH, or —NH 2 , R 22 denotes alkyl having 1 to 12 C atoms, and Sp a , Sp c each, independently of one another, denotes a spacer group or a single bond. 2. The liquid-crystal (LC) medium according to claim 1 comprising any of the following combinations of a first and a second self-alignment additive of formulae: IE and IG, IF and IG, IJ and IG, IJ and IL, IK and IL, IE and IL, IG and IK, or IF and IL. 3. The liquid-crystal (LC) medium according to claim 1 , wherein said two or more alignment additives each comprise one, two or more polymerizable groups. 4. The liquid-crystal (LC) medium according to claim 1 , comprising one or more self-alignment additives selected from the group consisting of formulae IE and IJ and one or more self-alignment additives selected from the group consisting of formulae IG and IL. 5. The liquid-crystal (LC) medium according to claim 1 , comprising one or more self-alignment additives of formula IJ and one or more compounds of formula IL. 6. The LC medium according to claim 1 , further comprising a polymerizable or polymerized compound other than compounds of formulae IG, IL, IE, IF, IJ and IK, where the polymerized component is obtainable by polymerization of a polymerizable component. 7. The medium according to claim 1 , wherein, in any of formulae IG, IL, IE, IF, IJ and IK, A 4 , A 5 , A 6 , A 7 , A 8 , A 9 , each, independently of one another, denote 1,4-phenylene, naphthalene-1,4-diyl or naphthalene-2,6-diyl, in which one or more CH groups are each optionally replaced by N, cyclohexane-1,4-diyl, in which one or more non-adjacent CH 2 groups are each optionally replaced by O or S, 3,3′-bicyclobutylidene, 1,4-cyclohexenylene, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, piperidine-1,4-diyl, decahydro-naphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indane-2,5-diyl, octahydro-4,7-methanoindane-2,5-diyl, or perhydrocyclopenta[a]phenanthrene-3,17-diyl, where any of which is unsubstituted or mono- or polysubstituted by a group L, and A 4 to A 6 is optionally substituted by a group -Sp-P, and A 7 to A 9 is optionally substituted by one, two or three groups -Sp-P. 8. The medium according to claim 1 , wherein the compound of formula IJ is a compound of formula IJ1, in which R 1 , A 7 , A 8 , A 9 , Z 2 , Z 3 , m, n, L, Sp a , X 1 , Sp and P independently are defined as for the compound of formula IJ, p1 is 2, and r1, r2, r3 independently are 0, 1, 2 or 3. 9. The medium according to claim 1 , wherein the compound of formula IK is a compound of formula IK1, in which R 1 , A 7 , A 8 , A 9 , Z 2 , Z 3 , m, n, L, Sp a , Sp c , X 1 , Sp and P independently are defined as for the compound of formula IK, P 1 is 2, and r1, r2, r3 independently are 0, 1, 2 or 3. 10. The medium according to claim 1 , wherein the one or more compounds of formula IJ are compounds of formulae IJ1-1 to IJ1-9: in which R 1 , Z 2 , Z 3 , L, Sp and P independently are as defined as for the compound of formula IJ, and x is 0 or 1, n is 1, 2, 3, 4, 5, 6, 7 or 8, p1 is 2, and r1, r2, r3, r3″ independently denote 0, 1, 2 or 3. 11. The medium according to claim 1 , wherein the one or more compounds of formula IK are compounds of formulae IK1-1 to IK1-9: in which R 1 , Z 2 , Z 3 , L, Sp, Spy and P independently are as defined as for the compound of formula IK, and x is 0 or 1, n is 1, 2, 3, 4, 5, 6, 7 or 8, p1 is 2, and r1, r2, r3, r3″ independently denote 0, 1, 2 or 3. 12. The medium according to claim 1 , wherein the compound of formula IJ is a compound of formula IJ1, in which R 1 , A 7 , A 8 , A 9 , Z 2 , Z 3 , m, n, L, Sp a , X 1 , Sp and P independently are defined as for the compound of formula IJ, p1 is 2, r1, r3 independently are 0, 1, 2 or 3, and r2 is 2, or wherein the compound of formula IK is a compound of formula IK1,

Assignees

Inventors

Classifications

  • C09K19/54Primary

    Additives having no specific mesophase {characterised by their chemical composition} · CPC title

  • containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings · CPC title

  • C09K19/04Primary

    characterised by the chemical structure of the liquid crystal components {, e.g. by a specific unit} · CPC title

  • based on liquid crystals, e.g. single liquid crystal display cells · CPC title

  • Macromolecular compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11072742B2 cover?
A liquid-crystalline media (LC media) containing a low-molecular-weight, non-polymer component, and a combination of self-alignment additives for vertical alignment of two or more of the specified kinds (formulae IA to IM). The combination of two or more self-alignment additives affect homeotropic (vertical) alignment of the LC media at a surface or the cell surfaces of a liquid-crystal display…
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/54. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).